On November 6, 2019, Gordon Keller, PhD, was presented with the 2019 Ogawa-Yamanaka Stem Cell Prize. A world-renowned stem cell scientist, Keller was selected for his contributions to efficient lineage-specific differentiation of human pluripotent stem cells into a myriad of cell types, enabling disease modeling and regenerative medicine approaches for many human diseases.
The Ogawa-Yamanaka Stem Cell Prize recognizes individuals whose original translational research has advanced cellular reprogramming technology for regenerative medicine. The prize was established in 2015 through a generous gift from the late Hiro and Betty Ogawa and is supported by the Gladstone Institutes. It also recognizes the importance of induced pluripotent stem cells (iPSCs), discovered by Gladstone Senior Investigator and Nobel laureate Shinya Yamanaka.
In 2019, Gladstone formed a partnership with the Cell Press group to support this important prize.
Support Discovery Science
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Rewinding Cells to Reverse Disease
Article
November 29, 2022
Rewinding Cells to Reverse Disease
Juan Carlos Izpisua Belmonte, recipient of the 2022 Ogawa-Yamanaka Stem Cell Prize, is turning back the clock on old and sick cells, with many potential benefits
Awards Ogawa Stem Cell Prize Profile Stem Cells/iPSCsNevan Krogan Wins France’s Highest Honor
Article
October 27, 2022
Nevan Krogan Wins France’s Highest Honor
Gladstone investigator is awarded the Legion of Honor
Awards Krogan LabGladstone Data Scientist Elected to the National Academy of Medicine
Article
October 17, 2022
Gladstone Data Scientist Elected to the National Academy of Medicine
Katie Pollard is recognized for discovering fast-evolving regions of the human genome and for creating open-source software used by scientists worldwide
Awards News Release Data Science and Biotechnology Pollard Lab Big Data